Effect of endurance for adverse drug reactions on the preference for aggressive treatments in cancer patients

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Supportive Care in Cancer

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00520-014-2439-1PMID 25294657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects.

  2014cited by this paper
• Comparing patient dissatisfaction and rational judgment in intentional medication non‐adherence versus unintentional non‐adherence

  2014cited by this paper
• What do cancer patients worry about when making decisions about treatment? Variation across racial/ethnic groups

  2013cited by this paper
• Preference weights for chemotherapy side effects from the perspective of women with breast cancer

  2013cited by this paper
• Patients’ views about causes and preferences for the management of cancer-related fatigue—a case for non-congruence with the physicians?

  2011cited by this paper
• Decision making and quality of life in the treatment of cancer: a review

  2009cited by this paper
• Quality of Life: The assessment, analysis and interpretation of patient-reported outcomes

  2007cited by this paper
• Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer

  2005cited by this paper
• What are cancer patients’ preferences about treatment at the end of life, and who should start talking about it? A comparison with healthy people and medical staff

  2005cited by this paper
• Review of determinants of patients' preferences for adjuvant therapy in cancer.

  2004influential reference
• Treatment preferences in recurrent ovarian cancer.

  2002cited by this paper
• Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

  2001cited by this paper
• Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?

  2001influential reference
• Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile.

  2001influential reference
• Patient preference for cancer therapy: an overview of measurement approaches.

  2001cited by this paper
• Framing of outcome and probability of recurrence: Breast cancer patients' choice of adjuvant chemotherapy (ACT) in hypothetical patient scenarios

  2000cited by this paper
• Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy.

  1998cited by this paper
• Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.

  1998cited by this paper
• Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.

  1990cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper

• Patient Preference for Aggressive Medication Therapies with Potentially Stronger Adverse Drug Reactions Revealed Using a Scenario-based Survey.

  2017cites this paper